Publikationen

Publikationen

(2011) Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Antoniou, A.C., C. Kartsonaki, O.M. Sinilnikova, P. Soucy, L. McGuffog, S. Healey, A. Lee, P. Peterlongo, S. Manoukian, B. Peissel, D. Zaffaroni, E. Cattaneo, M. Barile, V. Pensotti, B. Pasini, R. Dolcetti, G. Giannini, A.L. Putignano, L. Varesco, P. Radice, P.L. Mai, M.H. Greene, I.L. Andrulis, G. Glendon, H. Ozcelik, M. Thomassen, A.M. Gerdes, T.A. Kruse, U. Birk Jensen, D.G. Cruger, M.A. Caligo, Y. Laitman, R. Milgrom, B. Kaufman, S. Paluch-Shimon, E. Friedman, N. Loman, K. Harbst, A. Lindblom, B. Arver, H. Ehrencrona, B. Melin, B. Swe, K.L. Nathanson, S.M. Domchek, T. Rebbeck, A. Jakubowska, J. Lubinski, J. Gronwald, T. Huzarski, T. Byrski, C. Cybulski, B. Gorski, A. Osorio, T. Ramon y Cajal, F. Fostira, R. Andres, J. Benitez, U. Hamann, F.B. Hogervorst, M.A. Rookus, M.J. Hooning, M.R. Nelen, R.B. van der Luijt, T.A. van Os, C.J. van Asperen, P. Devilee, H.E. Meijers-Heijboer, E.B. Gomez Garcia, Hebon, S. Peock, M. Cook, D. Frost, R. Platte, J. Leyland, D.G. Evans, F. Lalloo, R. Eeles, L. Izatt, J. Adlard, R. Davidson, D. Eccles, K.R. Ong, J. Cook, F. Douglas, J. Paterson, M.J. Kennedy, Z. Miedzybrodzka, Embrace, A. Godwin, D. Stoppa-Lyonnet, B. Buecher, M. Belotti, C. Tirapo, S. Mazoyer, L. Barjhoux, C. Lasset, D. Leroux, L. Faivre, M. Bronner, F. Prieur, C. Nogues, E. Rouleau, P. Pujol, I. Coupier, M. Frenay, C.S. Collaborators, J.L. Hopper, M.B. Daly, M.B. Terry, E.M. John, S.S. Buys, Y. Yassin, A. Miron, D. Goldgar, R. Breast Cancer Family, C.F. Singer, M.K. Tea, G. Pfeiler, A.C. Dressler, T. Hansen, L. Jonson, B. Ejlertsen, R.B. Barkardottir, T. Kirchhoff, K. Offit, M. Piedmonte, G. Rodriguez, L. Small, J. Boggess, S. Blank, J. Basil, M. Azodi, A.E. Toland, M. Montagna, S. Tognazzo, S. Agata, E. Imyanitov, R. Janavicius, C. Lazaro, I. Blanco, P.D. Pharoah, L. Sucheston, B.Y. Karlan, C.S. Walsh, E. Olah, A. Bozsik, S.H. Teo, J.L. Seldon, M.S. Beattie, E.J. van Rensburg, M.D. Sluiter, O. Diez, R.K. Schmutzler, B. Wappenschmidt, C. Engel, A. Meindl, I. Ruehl, R. Varon-Mateeva, K. Kast, H. Deissler, D. Niederacher, N. Arnold, D. Gadzicki, I. Schonbuchner, T. Caldes, M. de la Hoya, H. Nevanlinna, K. Aittomaki, M. Dumont, J. Chiquette, M. Tischkowitz, X. Chen, J. Beesley, A.B. Spurdle, i. kConFab, S.L. Neuhausen, Y. Chun Ding, Z. Fredericksen, X. Wang, V.S. Pankratz, F. Couch, J. Simard, D.F. Easton, G. Chenevix-Trench and Cimba. Hum Mol Genet, 20(16): p. 3304-21.

Consortium of Investigators of Modifiers of (2011) Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

Cox, D.G., J. Simard, D. Sinnett, Y. Hamdi, P. Soucy, M. Ouimet, L. Barjhoux, C. Verny-Pierre, L. McGuffog, S. Healey, C. Szabo, M.H. Greene, P.L. Mai, I.L. Andrulis, N. Ontario Cancer Genetics, M. Thomassen, A.M. Gerdes, M.A. Caligo, E. Friedman, Y. Laitman, B. Kaufman, S.S. Paluch, A. Borg, P. Karlsson, M.S. Askmalm, G.B. Bustinza, S.-B. Collaborators, K.L. Nathanson, S.M. Domchek, T.R. Rebbeck, J. Benitez, U. Hamann, M.A. Rookus, A.M. van den Ouweland, M.G. Ausems, C.M. Aalfs, C.J. van Asperen, P. Devilee, H.J. Gille, Hebon, Embrace, S. Peock, D. Frost, D.G. Evans, R. Eeles, L. Izatt, J. Adlard, J. Paterson, J. Eason, A.K. Godwin, M.A. Remon, V. Moncoutier, M. Gauthier-Villars, C. Lasset, S. Giraud, A. Hardouin, P. Berthet, H. Sobol, F. Eisinger, B. Bressac de Paillerets, O. Caron, C. Delnatte, G.S. Collaborators, D. Goldgar, A. Miron, H. Ozcelik, S. Buys, M.C. Southey, M.B. Terry, R. Breast Cancer Family, C.F. Singer, A.C. Dressler, M.K. Tea, T.V. Hansen, O. Johannsson, M. Piedmonte, G.C. Rodriguez, J.B. Basil, S. Blank, A.E. Toland, M. Montagna, C. Isaacs, I. Blanco, S.A. Gayther, K.B. Moysich, R.K. Schmutzler, B. Wappenschmidt, C. Engel, A. Meindl, N. Ditsch, N. Arnold, D. Niederacher, C. Sutter, D. Gadzicki, B. Fiebig, T. Caldes, R. Laframboise, H. Nevanlinna, X. Chen, J. Beesley, A.B. Spurdle, S.L. Neuhausen, Y.C. Ding, F.J. Couch, X. Wang, P. Peterlongo, S. Manoukian, L. Bernard, P. Radice, D.F. Easton, G. Chenevix-Trench, A.C. Antoniou, D. Stoppa-Lyonnet, S. Mazoyer, O.M. Sinilnikova and B.. Hum Mol Genet, 20(23): p. 4732-47.

(2011) Challenges to the development of new agents for molecularly defined patient subsets: lessons from BRCA1/2-associated breast cancer.

Domchek, S.M., G. Mitchell, G.J. Lindeman, N.M. Tung, J. Balmana, S.J. Isakoff, R. Schmutzler, M.W. Audeh, N. Loman, C. Scott, M. Friedlander, B. Kaufman, J.E. Garber, A. Tutt, and M.E. Robson. J Clin Oncol, 29(32): p. 4224-6.

(2011) Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer.

Hellebrand, H., C. Sutter, E. Honisch, E. Gross, B. Wappenschmidt, C. Schem, H. Deissler, N. Ditsch, V. Gress, M. Kiechle, C.R. Bartram, R.K. Schmutzler, D. Niederacher, N. Arnold, and A. Meindl. Hum Mutat, 32(6): p. E2176-88.

(2011) Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

Im, K.M., T. Kirchhoff, X. Wang, T. Green, C.Y. Chow, J. Vijai, J. Korn, M.M. Gaudet, Z. Fredericksen, V. Shane Pankratz, C. Guiducci, A. Crenshaw, L. McGuffog, C. Kartsonaki, J. Morrison, S. Healey, O.M. Sinilnikova, P.L. Mai, M.H. Greene, M. Piedmonte, W.S. Rubinstein, Hebon, F.B. Hogervorst, M.A. Rookus, J.M. Collee, N. Hoogerbrugge, C.J. van Asperen, H.E. Meijers-Heijboer, C.E. Van Roozendaal, T. Caldes, P. Perez-Segura, A. Jakubowska, J. Lubinski, T. Huzarski, P. Blecharz, H. Nevanlinna, K. Aittomaki, C. Lazaro, I. Blanco, R.B. Barkardottir, M. Montagna, E. D'Andrea, kConFab, P. Devilee, O.I. Olopade, S.L. Neuhausen, B. Peissel, B. Bonanni, P. Peterlongo, C.F. Singer, G. Rennert, F. Lejbkowicz, I.L. Andrulis, G. Glendon, H. Ozcelik, N. Ontario Cancer Genetics, A.E. Toland, M.A. Caligo, B. Swe, M.S. Beattie, S. Chan, Ukfocr, S.M. Domchek, K.L. Nathanson, T.R. Rebbeck, C. Phelan, S. Narod, E.M. John, J.L. Hopper, S.S. Buys, M.B. Daly, M.C. Southey, M.B. Terry, N. Tung, T.V. Hansen, A. Osorio, J. Benitez, M. Duran, J.N. Weitzel, J. Garber, U. Hamann, Embrace, S. Peock, M. Cook, C.T. Oliver, D. Frost, R. Platte, D.G. Evans, R. Eeles, L. Izatt, J. Paterson, C. Brewer, S. Hodgson, P.J. Morrison, M. Porteous, L. Walker, M.T. Rogers, L.E. Side, A.K. Godwin, R.K. Schmutzler, B. Wappenschmidt, Y. Laitman, A. Meindl, H. Deissler, R. Varon-Mateeva, S. Preisler-Adams, K. Kast, L. Venat-Bouvet, D. Stoppa-Lyonnet, G. Chenevix-Trench, D.F. Easton, R.J. Klein, M.J. Daly, E. Friedman, M. Dean, A.G. Clark, D.M. Altshuler, A.C. Antoniou, F.J. Couch, K. Offit and B. Gold. Hum Genet, 130(5): p. 685-99.

(2011) Familiärer Brust- und Eierstockkrebs – Was gibt es Neues? .

Kast K, M.A., Schmutzler RK. Onkologie 6: p. 4-10.

Kast K, S.R., BRCA12-BRCA2-Prävention-Früherkennung-Mammakarzinom., in Prävention und Früherkennung bei Frauen mit familiärer Krebsbelastung –Empfehlungen des Deutschen Konsortiums „Familiärer Brust- und Eierstockkrebs“.

G. Praxis, Editor. 2011, Marseille Verlag.

(2011) Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.

Maxwell, C.A., J. Benitez, L. Gomez-Baldo, A. Osorio, N. Bonifaci, R. Fernandez-Ramires, S.V. Costes, E. Guino, H. Chen, G.J. Evans, P. Mohan, I. Catala, A. Petit, H. Aguilar, A. Villanueva, A. Aytes, J. Serra-Musach, G. Rennert, F. Lejbkowicz, P. Peterlongo, S. Manoukian, B. Peissel, C.B. Ripamonti, B. Bonanni, A. Viel, A. Allavena, L. Bernard, P. Radice, E. Friedman, B. Kaufman, Y. Laitman, M. Dubrovsky, R. Milgrom, A. Jakubowska, C. Cybulski, B. Gorski, K. Jaworska, K. Durda, G. Sukiennicki, J. Lubinski, Y.Y. Shugart, S.M. Domchek, R. Letrero, B.L. Weber, F.B. Hogervorst, M.A. Rookus, J.M. Collee, P. Devilee, M.J. Ligtenberg, R.B. Luijt, C.M. Aalfs, Q. Waisfisz, J. Wijnen, C.E. Roozendaal, Hebon, Embrace, D.F. Easton, S. Peock, M. Cook, C. Oliver, D. Frost, P. Harrington, D.G. Evans, F. Lalloo, R. Eeles, L. Izatt, C. Chu, D. Eccles, F. Douglas, C. Brewer, H. Nevanlinna, T. Heikkinen, F.J. Couch, N.M. Lindor, X. Wang, A.K. Godwin, M.A. Caligo, G. Lombardi, N. Loman, P. Karlsson, H. Ehrencrona, A. Wachenfeldt, B. Swe, R.B. Barkardottir, U. Hamann, M.U. Rashid, A. Lasa, T. Caldes, R. Andres, M. Schmitt, V. Assmann, K. Stevens, K. Offit, J. Curado, H. Tilgner, R. Guigo, G. Aiza, J. Brunet, J. Castellsague, G. Martrat, A. Urruticoechea, I. Blanco, L. Tihomirova, D.E. Goldgar, S. Buys, E.M. John, A. Miron, M. Southey, M.B. Daly, Bcfr, R.K. Schmutzler, B. Wappenschmidt, A. Meindl, N. Arnold, H. Deissler, R. Varon-Mateeva, C. Sutter, D. Niederacher, E. Imyamitov, O.M. Sinilnikova, D. Stoppa-Lyonne, S. Mazoyer, C. Verny-Pierre, L. Castera, A. de Pauw, Y.J. Bignon, N. Uhrhammer, J.P. Peyrat, P. Vennin, S. Fert Ferrer, M.A. Collonge-Rame, I. Mortemousque, G.S. Collaborators, A.B. Spurdle, J. Beesley, X. Chen, S. Healey, kConFab, M.H. Barcellos-Hoff, M. Vidal, S.B. Gruber, C. Lazaro, G. Capella, L. McGuffog, K.L. Nathanson, A.C. Antoniou, G. Chenevix-Trench, M.C. Fleisch, V. Moreno and M.A. Pujana. PLoS Biol, 9(11): p. e1001199.

(2011) Hereditary breast and ovarian cancer: new genes, new treatments, new concepts.

Meindl, A., N. Ditsch, K. Kast, K. Rhiem, and R.K. Schmutzler. Dtsch Arztebl Int, 108(19): p. 323-30.

(2011) Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.

Milne, R.L., E.L. Goode, M. Garcia-Closas, F.J. Couch, G. Severi, R. Hein, Z. Fredericksen, N. Malats, M.P. Zamora, J.I. Arias Perez, J. Benitez, T. Dork, P. Schurmann, J.H. Karstens, P. Hillemanns, A. Cox, I.W. Brock, G. Elliot, S.S. Cross, S. Seal, C. Turnbull, A. Renwick, N. Rahman, C.Y. Shen, J.C. Yu, C.S. Huang, M.F. Hou, B.G. Nordestgaard, S.E. Bojesen, C. Lanng, G. Grenaker Alnaes, V. Kristensen, A.L. Borrensen-Dale, J.L. Hopper, G.S. Dite, C. Apicella, M.C. Southey, D. Lambrechts, B.T. Yesilyurt, G. Floris, K. Leunen, S. Sangrajrang, V. Gaborieau, P. Brennan, J. McKay, J. Chang-Claude, S. Wang-Gohrke, P. Radice, P. Peterlongo, S. Manoukian, M. Barile, G.G. Giles, L. Baglietto, E.M. John, A. Miron, S.J. Chanock, J. Lissowska, M.E. Sherman, J.D. Figueroa, N.V. Bogdanova, N.N. Antonenkova, I.V. Zalutsky, Y.I. Rogov, P.A. Fasching, C.M. Bayer, A.B. Ekici, M.W. Beckmann, H. Brenner, H. Muller, V. Arndt, C. Stegmaier, I.L. Andrulis, J.A. Knight, G. Glendon, A.M. Mulligan, A. Mannermaa, V. Kataja, V.M. Kosma, J.M. Hartikainen, A. Meindl, J. Heil, C.R. Bartram, R.K. Schmutzler, G.D. Thomas, R.N. Hoover, O. Fletcher, L.J. Gibson, I. dos Santos Silva, J. Peto, S. Nickels, D. Flesch-Janys, H. Anton-Culver, A. Ziogas, E. Sawyer, I. Tomlinson, M. Kerin, N. Miller, M.K. Schmidt, A. Broeks, L.J. Van 't Veer, R.A. Tollenaar, P.D. Pharoah, A.M. Dunning, K.A. Pooley, F. Marme, A. Schneeweiss, C. Sohn, B. Burwinkel, A. Jakubowska, J. Lubinski, K. Jaworska, K. Durda, D. Kang, K.Y. Yoo, D.Y. Noh, S.H. Ahn, D.J. Hunter, S.E. Hankinson, P. Kraft, S. Lindstrom, X. Chen, J. Beesley, U. Hamann, V. Harth, C. Justenhoven, G. Network, R. Winqvist, K. Pylkas, A. Jukkola-Vuorinen, M. Grip, M. Hooning, A. Hollestelle, R.A. Oldenburg, M. Tilanus-Linthorst, E. Khusnutdinova, M. Bermisheva, D. Prokofieva, A. Farahtdinova, J.E. Olson, X. Wang, M.K. Humphreys, Q. Wang, G. Chenevix-Trench, I. kConFab, A. Group and D.F. Easton. Cancer Epidemiol Biomarkers Prev, 20(10): p. 2222-31.

(2011) Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

Mulligan, A.M., F.J. Couch, D. Barrowdale, S.M. Domchek, D. Eccles, H. Nevanlinna, S.J. Ramus, M. Robson, M. Sherman, A.B. Spurdle, B. Wappenschmidt, A. Lee, L. McGuffog, S. Healey, O.M. Sinilnikova, R. Janavicius, T. Hansen, F.C. Nielsen, B. Ejlertsen, A. Osorio, I. Munoz-Repeto, M. Duran, J. Godino, M. Pertesi, J. Benitez, P. Peterlongo, S. Manoukian, B. Peissel, D. Zaffaroni, E. Cattaneo, B. Bonanni, A. Viel, B. Pasini, L. Papi, L. Ottini, A. Savarese, L. Bernard, P. Radice, U. Hamann, M. Verheus, H.E. Meijers-Heijboer, J. Wijnen, E.B. Gomez Garcia, M.R. Nelen, C.M. Kets, C. Seynaeve, M.M. Tilanus-Linthorst, R.B. van der Luijt, T. van Os, M. Rookus, D. Frost, J.L. Jones, D.G. Evans, F. Lalloo, R. Eeles, L. Izatt, J. Adlard, R. Davidson, J. Cook, A. Donaldson, H. Dorkins, H. Gregory, J. Eason, C. Houghton, J. Barwell, L.E. Side, E. McCann, A. Murray, S. Peock, A.K. Godwin, R.K. Schmutzler, K. Rhiem, C. Engel, A. Meindl, I. Ruehl, N. Arnold, D. Niederacher, C. Sutter, H. Deissler, D. Gadzicki, K. Kast, S. Preisler-Adams, R. Varon-Mateeva, I. Schoenbuchner, B. Fiebig, W. Heinritz, D. Schafer, H. Gevensleben, V. Caux-Moncoutier, M. Fassy-Colcombet, F. Cornelis, S. Mazoyer, M. Leone, N. Boutry-Kryza, A. Hardouin, P. Berthet, D. Muller, J.P. Fricker, I. Mortemousque, P. Pujol, I. Coupier, M. Lebrun, C. Kientz, M. Longy, N. Sevenet, D. Stoppa-Lyonnet, C. Isaacs, T. Caldes, M. de la Hoya, T. Heikkinen, K. Aittomaki, I. Blanco, C. Lazaro, R.B. Barkardottir, P. Soucy, M. Dumont, J. Simard, M. Montagna, S. Tognazzo, E. D'Andrea, S. Fox, M. Yan, T. Rebbeck, O. Olopade, J.N. Weitzel, H.T. Lynch, P.A. Ganz, G.E. Tomlinson, X. Wang, Z. Fredericksen, V.S. Pankratz, N.M. Lindor, C. Szabo, K. Offit, R. Sakr, M. Gaudet, J. Bhatia, N. Kauff, C.F. Singer, M.K. Tea, D. Gschwantler-Kaulich, A. Fink-Retter, P.L. Mai, M.H. Greene, E. Imyanitov, F.P. O'Malley, H. Ozcelik, G. Glendon, A.E. Toland, A.M. Gerdes, M. Thomassen, T.A. Kruse, U.B. Jensen, A.B. Skytte, M.A. Caligo, M. Soller, K. Henriksson, A. Wachenfeldt v, B. Arver, M. Stenmark-Askmalm, P. Karlsson, Y.C. Ding, S.L. Neuhausen, M. Beattie, P.D. Pharoah, K.B. Moysich, K.L. Nathanson, B.Y. Karlan, J. Gross, E.M. John, M.B. Daly, S.M. Buys, M.C. Southey, J.L. Hopper, M.B. Terry, W. Chung, A.F. Miron, D. Goldgar, G. Chenevix-Trench, D.F. Easton, I.L. Andrulis, A.C. Antoniou, R. Breast Cancer Family, Embrace, G.S. Collaborators, Hebon, I. kConFab, N. Ontario Cancer Genetics, B. Swe and Cimba. Breast Cancer Res, 13(6): p. R110.

(2011) High nuclear poly(adenosine diphosphate-ribose) polymerase expression is predictive for BRCA1- and BRCA2-deficient breast cancer.

Ozretic, L., K. Rhiem, S. Huss, B. Wappenschmidt, B. Markiefka, P. Sinn, R.K. Schmutzler, and R. Buettner. J Clin Oncol, 29(34): p. 4586-8; author reply 4588.

(2011) The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.

Pharoah, P.D., R.T. Palmieri, S.J. Ramus, S.A. Gayther, I.L. Andrulis, H. Anton-Culver, N. Antonenkova, A.C. Antoniou, D. Goldgar, B. Investigators, M.S. Beattie, M.W. Beckmann, M.J. Birrer, N. Bogdanova, K.L. Bolton, W. Brewster, A. Brooks-Wilson, R. Brown, R. Butzow, T. Caldes, M.A. Caligo, I. Campbell, J. Chang-Claude, Y.A. Chen, L.S. Cook, F.J. Couch, D.W. Cramer, J.M. Cunningham, E. Despierre, J.A. Doherty, T. Dork, M. Durst, D.M. Eccles, A.B. Ekici, D. Easton, E. Investigators, P.A. Fasching, A. de Fazio, D.A. Fenstermacher, J.M. Flanagan, B.L. Fridley, E. Friedman, B. Gao, O. Sinilnikova, G.S. Collaborators, A. Gentry-Maharaj, A.K. Godwin, E.L. Goode, M.T. Goodman, J. Gross, T.V. Hansen, P. Harnett, M. Rookus, H. Investigators, T. Heikkinen, R. Hein, C. Hogdall, E. Hogdall, E.S. Iversen, A. Jakubowska, S.E. Johnatty, B.Y. Karlan, N.D. Kauff, S.B. Kaye, G. Chenevix-Trench, I. kConFab, B. the Consortium of Investigators of Modifiers of, L.E. Kelemen, L.A. Kiemeney, S.K. Kjaer, D. Lambrechts, J.P. Lapolla, C. Lazaro, N.D. Le, A. Leminen, K. Leunen, D.A. Levine, Y. Lu, L. Lundvall, S. Macgregor, T. Marees, L.F. Massuger, J.R. McLaughlin, U. Menon, M. Montagna, K.B. Moysich, S.A. Narod, K.L. Nathanson, L. Nedergaard, R.B. Ness, H. Nevanlinna, S. Nickels, A. Osorio, J. Paul, C.L. Pearce, C.M. Phelan, M.C. Pike, P. Radice, M.A. Rossing, J.M. Schildkraut, T.A. Sellers, C.F. Singer, H. Song, D.O. Stram, R. Sutphen, A. Lindblom, S.-B. Investigators, K.L. Terry, Y.Y. Tsai, A.M. van Altena, I. Vergote, R.A. Vierkant, A.F. Vitonis, C. Walsh, S. Wang-Gohrke, B. Wappenschmidt, A.H. Wu, A. Ziogas, A. Berchuck, H.A. Risch and C. Ovarian Cancer Association. Clin Cancer Res, 17(11): p. 3742-50.

Consortium of Investigators of Modifiers of (2011) Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

Ramus, S.J., C. Kartsonaki, S.A. Gayther, P.D. Pharoah, O.M. Sinilnikova, J. Beesley, X. Chen, L. McGuffog, S. Healey, F.J. Couch, X. Wang, Z. Fredericksen, P. Peterlongo, S. Manoukian, B. Peissel, D. Zaffaroni, G. Roversi, M. Barile, A. Viel, A. Allavena, L. Ottini, L. Papi, V. Gismondi, F. Capra, P. Radice, M.H. Greene, P.L. Mai, I.L. Andrulis, G. Glendon, H. Ozcelik, Ocgn, M. Thomassen, A.M. Gerdes, T.A. Kruse, D. Cruger, U.B. Jensen, M.A. Caligo, H. Olsson, U. Kristoffersson, A. Lindblom, B. Arver, P. Karlsson, M. Stenmark Askmalm, A. Borg, S.L. Neuhausen, Y.C. Ding, K.L. Nathanson, S.M. Domchek, A. Jakubowska, J. Lubinski, T. Huzarski, T. Byrski, J. Gronwald, B. Gorski, C. Cybulski, T. Debniak, A. Osorio, M. Duran, M.I. Tejada, J. Benitez, U. Hamann, M.A. Rookus, S. Verhoef, M.A. Tilanus-Linthorst, M.P. Vreeswijk, D. Bodmer, M.G. Ausems, T.A. van Os, C.J. Asperen, M.J. Blok, H.E. Meijers-Heijboer, Hebon, Embrace, S. Peock, M. Cook, C. Oliver, D. Frost, A.M. Dunning, D.G. Evans, R. Eeles, G. Pichert, T. Cole, S. Hodgson, C. Brewer, P.J. Morrison, M. Porteous, M.J. Kennedy, M.T. Rogers, L.E. Side, A. Donaldson, H. Gregory, A. Godwin, D. Stoppa-Lyonnet, V. Moncoutier, L. Castera, S. Mazoyer, L. Barjhoux, V. Bonadona, D. Leroux, L. Faivre, R. Lidereau, C. Nogues, Y.J. Bignon, F. Prieur, M.A. Collonge-Rame, L. Venat-Bouvet, S. Fert-Ferrer, G.S. Collaborators, A. Miron, S.S. Buys, J.L. Hopper, M.B. Daly, E.M. John, M.B. Terry, D. Goldgar, Bcfr, T.O. Hansen, L. Jonson, B. Ejlertsen, B.A. Agnarsson, K. Offit, T. Kirchhoff, J. Vijai, A.V. Dutra-Clarke, J.A. Przybylo, M. Montagna, C. Casella, E.N. Imyanitov, R. Janavicius, I. Blanco, C. Lazaro, K.B. Moysich, B.Y. Karlan, J. Gross, M.S. Beattie, R. Schmutzler, B. Wappenschmidt, A. Meindl, I. Ruehl, B. Fiebig, C. Sutter, N. Arnold, H. Deissler, R. Varon-Mateeva, K. Kast, D. Niederacher, D. Gadzicki, T. Caldes, M. de la Hoya, H. Nevanlinna, K. Aittomaki, J. Simard, P. Soucy, I. kConFab, A.B. Spurdle, H. Holland, G. Chenevix-Trench, D.F. Easton, A.C. Antoniou and B.. J Natl Cancer Inst, 103(2): p. 105-16.

(2011) Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rhiem, K., D. Foth, B. Wappenschmidt, H. Gevensleben, R. Buttner, U. Ulrich, and R.K. Schmutzler. Arch Gynecol Obstet, 283(3): p. 623-7.

(2011) Hereditäre Mamma- und Genitalkarzinome.

Rhiem K, S.R.. Frauenheilkunde 6: p. 369-78.

(2011) Preventive Surgery.

Schmutzler RK, D.S.. Breast Care, 6: p. 153.

Das hereditäre Mammakarzinom: Genetik, Prävention und Therapie.

Schmutzler RK, M.A. , in Aktuelle Empfehlungen zur Therapie primärer und forteschrittener Mammakarzinome 2011, K. Mamma, Editor. 2011, Zuckschwerdt Verlag.

(2011) Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.

Stevens, K.N., M. Garcia-Closas, Z. Fredericksen, M. Kosel, V.S. Pankratz, J.L. Hopper, G.S. Dite, C. Apicella, M.C. Southey, M.K. Schmidt, A. Broeks, L.J. Van 't Veer, R.A. Tollenaar, P.A. Fasching, M.W. Beckmann, A. Hein, A.B. Ekici, N. Johnson, J. Peto, I. dos Santos Silva, L. Gibson, E. Sawyer, I. Tomlinson, M.J. Kerin, S. Chanock, J. Lissowska, D.J. Hunter, R.N. Hoover, G.D. Thomas, R.L. Milne, J.I. Arias Perez, A. Gonzalez-Neira, J. Benitez, B. Burwinkel, A. Meindl, R.K. Schmutzler, C.R. Bartrar, U. Hamann, Y.D. Ko, T. Bruning, J. Chang-Claude, R. Hein, S. Wang-Gohrke, T. Dork, P. Schurmann, M. Bremer, P. Hillemanns, N. Bogdanova, J.V. Zalutsky, Y.I. Rogov, N. Antonenkova, A. Lindblom, S. Margolin, A. Mannermaa, V. Kataja, V.M. Kosma, J. Hartikainen, G. Chenevix-Trench, X. Chen, P. Peterlongo, B. Bonanni, L. Bernard, S. Manoukian, X. Wang, J. Cerhan, C.M. Vachon, J. Olson, G.G. Giles, L. Baglietto, C.A. McLean, G. Severi, E.M. John, A. Miron, R. Winqvist, K. Pylkas, A. Jukkola-Vuorinen, M. Grip, I. Andrulis, J.A. Knight, G. Glendon, A.M. Mulligan, A. Cox, I.W. Brock, G. Elliott, S.S. Cross, P.P. Pharoah, A.M. Dunning, K.A. Pooley, M.K. Humphreys, J. Wang, D. Kang, K.Y. Yoo, D.Y. Noh, S. Sangrajrang, V. Gabrieau, P. Brennan, J. McKay, H. Anton-Culver, A. Ziogas, F.J. Couch, D.F. Easton, G. Network, I. kConFab and G. Australian Ovarian Cancer Study. Br J Cancer, 105(12): p. 1934-9.

(2011) The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.

von Minckwitz, G., S. Loibl, C. Jackisch, S. Paepke, C. Nestle-Kraemling, M.P. Lux, N. Maass, R. Schmutzler, A. du Bois, D. Wallwiener, S. Vescia, K. Budischewski, and M. Kaufmann. Cancer Epidemiol Biomarkers Prev, 20(10): p. 2141-9.

(2011) A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.

Wang, F., Z. Hu, R. Yang, J. Tang, Y. Liu, K. Hemminki, C. Sutter, B. Wappenschmidt, D. Niederacher, N. Arnold, A. Meindl, C.R. Bartram, R.K. Schmutzler, B. Burwinkel, and H. Shen. Breast Cancer Res Treat, 127(3): p. 769-75.

(2011) Further studies based on better design are needed to explore the association of NPAS2 gene polymorphisms with breast cancer.

Wang, F. and Y.F. Zou. Breast Cancer Res Treat, 127(2): p. 565-8.

(2011) Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.

Yang, R., M. Dick, F. Marme, A. Schneeweiss, A. Langheinz, K. Hemminki, C. Sutter, P. Bugert, B. Wappenschmidt, R. Varon, S. Schott, B.H. Weber, D. Niederacher, N. Arnold, A. Meindl, C.R. Bartram, R.K. Schmutzler, H. Muller, V. Arndt, H. Brenner, C. Sohn, and B. Burwinkel. Breast Cancer Res Treat, 127(2): p. 549-54.